AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05250258 — intervention group
Intervention type: OTHER
Intervention: Telephone peer support by telephone
Description: Peer support by telephone from experienced father to new father with depressive symtoms.~4 times or more if requested during 4 months
Study NCT00960921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron sucrose
Description: An intravenous infusion of 100 mg of iron is administered on days 0, 4, 8, 12, 16 and 20 of the study, giving a total of six iron infusions for each participant in the iron group over the course of the 28-day study period.
Study NCT00960921 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: An intravenous infusion of 100 ml of normal (0.9 %) saline is administered on days 0, 4, 8, 12, 16 and 20 of the study, giving a total of six saline (placebo) infusions for each participant in the saline group over the course of the 28-day study period.
Study NCT06220383 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hall technique
Description: Prepless crown technique
Study NCT06220383 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional technique
Description: 1 or 1,5 mm preparation on mesial, distal and occlusal of the tooth
Study NCT05613998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GPR Group
Description: 6-week treatment using the GPR method. 1 weekly session (45 min) with frog on the ground and sitting postures + daily home self-postures (10 min)
Study NCT05613998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercice Group
Description: 6-week nonspecific aerobic exercise treatment. Participants will take a daily walk (20 min)
Study NCT06347029 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Urine sampling
Description: Urine sampling
Study NCT06347029 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sampling
Description: Blood sampling
Study NCT05153200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Upadacitinib
Description: 15 mg po daily
Study NCT05153200 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab
Description: 40 mg sc every other week
Study NCT06482684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KTE-X19
Description: See description of treatment arms
Study NCT06482684 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: See description of treatment arms
Study NCT05714605 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: THRIVE Intervention
Description: The THRIVE Clinical Pathway is a standardized transitional care clinical pathway that supports Medicaid insured or Medicaid eligible individuals following hospitalization.
Study NCT06413784 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Morning chronotype
Description: Sleep quality, gestational diabetes and pregnancy symptoms of morning chronotype individuals were examined.
Study NCT06413784 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermediate chronotype
Description: Sleep quality, gestational diabetes and pregnancy symptoms of intermediate chronotype individuals were examined.
Study NCT06413784 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evening chronotype
Description: Sleep quality, gestational diabetes and pregnancy symptoms of evening chronotype individuals were examined.
Study NCT06482684 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibrutinib
Description: See description of treatment arms
Study NCT05779306 — intervention group
Intervention type: DEVICE
Intervention: IOL Master 700
Description: Biometry using the IOL Master 700
Study NCT05779306 — intervention group
Intervention type: DEVICE
Intervention: Casia-2
Description: Anterior segment-OCT to evaluate lens tilt
Study NCT05779306 — intervention group
Intervention type: DEVICE
Intervention: MS-39
Description: Corneal Topography using the MS-39
Study NCT05779306 — intervention group
Intervention type: DEVICE
Intervention: OSIRIS
Description: Abberometry using the OSIRIS-Abberometer
Study NCT05779306 — intervention group
Intervention type: DEVICE
Intervention: Autorefractor
Description: Evaluation of Refraction using an Autorefractor
Study NCT05779306 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Subjective Refraction
Description: Refraction performed by experienced staff
Study NCT06202183 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Program
Description: A 12 week, home-based, virtually supervised, aerobic and resistance exercise training program comprised of 36 sessions. Participants will be provided with a home stationary bike, resistance bands, and Fitbit. Virtually supervised sessions will be accessible via Zoom platform. For participants who do not have a device, a Wi-Fi-enabled tablet will also be provided.
Study NCT05003388 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AlloRx
Description: cultured allogeneic adult umbilical cord derived mesenchymal stem cells
Study NCT05529745 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurorehabilitation cerebellar cognitive disorder
Description: Influence of neurorehabilitation treatment lines of physiotherapy and exercise therapy including scheduled occupational therapy to adapt and improve cognitive-affective disorders in cerebellar lesions.
Study NCT05529745 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurorehabilitation cerebellar cognitive disorder
Description: Influence of neurorehabilitation treatment lines of physiotherapy and exercise therapy including scheduled occupational therapy to adapt and improve cognitive-affective disorders in cerebellar lesions.
Study NCT05453747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: After evaluating the age groups and physical characteristics of the athletes under the titles of Warm-Up, Core/Balance/Reactive, Speed/Agility/Quickness, Resistance and Cool-Down, the exercise programs that differ for the athlete under these exercise types are listed with the NASM program and shared with the athletes. During the 8-week period between the 2 evaluations, it was applied 2 days a week on the team's fitness days.
Study NCT05453747 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise 2
Description: After evaluating the age groups and physical characteristics of the athletes under the titles of Warm-Up, Core/Balance/Reactive, Speed/Agility/Quickness, Resistance and Cool-Down, the exercise programs that differ for the athlete under these exercise types are listed with the NASM program and shared with the athletes. During the 8-week period between the 2 evaluations, it was applied 2 days a week on the team's fitness days.
Study NCT06172608 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: psychoeducational intervention
Description: . Intervention group (I) will receive psychosocial education which will be consist of two parts. 1) Face to Face 2) Community based intervention.~1. Face to face: This face to face session will be consisting of 30-minute session soon after inclusion into the study. A leaflet consisting of all information will be provided to all the patents taking part in the study.~2. Community Based Intervention: In community based interventions prerecorded videos about all the topics covered in face to face session will be made available to parents via a secure online platform. Parents can easily browse it easily when they need it. These videos will be recorded in local language (Urdu), which is easy to understand for almost all the people.
Study NCT06167551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mother lullaby group
Description: mother's lullaby: the mother will be made to sing her own lullaby 5 minutes before the heel prick.
Study NCT06167551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: white noise group
Description: white noise: 5 minutes before taking heel prick blood, white noise will be started to be played on an MP3 player with white noise. The MP3 player will be placed in the crib where the baby lies, at the baby's bedside, at least 20 cm away from the baby's head. After the MP3 player is turned on, the sound level will be measured at the baby's ear level with a decibel meter and adjusted so that it does not exceed 70 decibels.
Study NCT06167551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: classical music group
Description: classical music: 5 minutes before heel prick, classical music will be started to be played from the MP3 player with white noise. The MP3 will be placed inside the crib where the baby lies, at the baby's bedside, at least 20 cm away from the baby's head. After the MP3 player is turned on, the sound level will be measured at the baby's ear level with a decibel meter and adjusted so that it does not exceed 70 decibels.
Study NCT06167551 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Contol Group
Description: No intervation
Study NCT04898712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid 500 MG
Description: Tranexamic Acid 500mg oral tablets
Study NCT04898712 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo will consist of an identical capsule to over-encapsulated tranexamic acid oral tablet entirely filled with microcrystalline cellulose, and sealed.
Study NCT04485130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disulfiram
Description: This study will provide disulfiram. Participants in Cohort 1 receiving disulfiram will take 2 capsules of disulfiram (each capsule contains 500 mg DSF plus 27.75 mg microcrystalline cellulose powder) per day for a total of 5 consecutive days. Participants in Cohort 2 receiving placebo will take 4 capsules of disulfiram (each capsule contains 500 mg DSF plus 27.75 mg microcrystalline cellulose powder) per day for a total of 5 consecutive days.
Study NCT04485130 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This study will provide placebo. Participants in Cohort 1 receiving placebo will take 2 capsules of placebo (each capsule contains only microcrystalline cellulose powder) per day for a total of 5 consecutive days. Participants in Cohort 2 receiving placebo will take 4 capsules of placebo (each capsule contains only microcrystalline cellulose powder) per day for a total of 5 consecutive days
Study NCT05784805 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PLIFU
Description: Participants will be treated with up to 2 sessions of PLIFU (on the same day), while monitored with surface EEG and will be observed for the remainder of the hospital stay as deemed by the primary care team. The system non-invasively delivers ultrasound sonications intracranially that selectively target specific areas of the brain.
Study NCT04888247 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CLARITY
Description: Trans-septal mitral valve replacement
Study NCT05889923 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: With EDU
Description: using the EDU to perform the procedure
Study NCT06205797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HU-045
Description: HU-045 is a medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary). It should be reconstituted with sterile, preservative-free 0.9% saline before use.~White powder~Other Names:~IncobotulinumtoxinA
Study NCT06205797 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xeomin®
Description: Xeomin® is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a short period of time (temporary). It should be reconstituted with sterile, preservative-free 0.9% saline before use.~Other Names:~IncobotulinumtoxinA
Study NCT05336201 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)
Description: Manualized cognitive remediation intervention that includes 1) skills-based remediation (metacognitive training), 2) parent training, and 3) cognitive behavioral approaches. Intervention targets self-management and goal-setting skill building to promote independence in activities necessary for transition of care.
Study NCT05336201 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)
Description: Manualized cognitive remediation intervention that includes 1) skills-based remediation (metacognitive training), 2) parent training, and 3) cognitive behavioral approaches. Intervention targets self-management and goal-setting skill building to promote independence in activities necessary for transition of care.
Study NCT05520840 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: blood sampling for screening of biomarkers
Description: Patient aged 50 years or older referred for screening colonoscopy after a positive fecal immunochemical test or for endoscopic resection of a previously identified suspicious colorectal lesion will have a blood sampling for biomarkers detection
Study NCT04662463 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification for Interpretation (CBM-I)
Description: Patients will receive CBM-I training by reading and imaging themselves in a series of emotionally ambiguous scenarios. Each scenario ends with an incomplete final word. Patients need to complete the final word to resolve the scenario in a positive direction.
Study NCT04662463 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive placebo task which uses neutral rather than emotional material.
Study NCT06004856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib
Description: Orelabrutinib once daily (QD)
Study NCT06004856 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once daily (QD)
Study NCT06559943 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Traditional Physiotherapy + Placebo Kinesio Tape
Description: Following a total of 15 sessions of electrophysical agent and exercise training, 5 days a week, for 3 weeks, each session lasting 45 minutes, followed by traditional physiotherapy, 2 days a week, for 3 weeks, a total of 6 times, with 0% tension applied to the trapezius muscle in the neck region (I). Kinesiotape will be applied.~The tape will be applied twice a week in total, staying for 3 days and leaving one day free after each application.
Study NCT06559943 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Physiotherapy + Kinesio Tape Treatment with Inhibition Method
Description: In addition to a total of 15 sessions of electrophysical agents and exercise training, 5 days a week for 3 weeks, each session lasting 45 minutes, kinesio tape will be applied 6 times in total, 2 days a week. Kinesiotape will be cut into an (I) shape (15 cm) with 50% tension and adhered laterally to the C7 joint. In acute cases such as overuse and muscle spasm, it is recommended to apply an inhibition technique that will inhibit the muscle. In the inhibition technique, the direction of the tape should be from the entry point of the muscle to the starting point and the application should be done with very light or light (15 - 25%) tension. In chronic cases, a facilitation technique should be applied to stimulate the weak muscle. The direction of the tape should be from the starting point of the muscle to the attachment point and the application should be done with light or moderate tension (25 - 50%).
Study NCT05667779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QRL-101
Description: Single-ascending doses of QRL-101 will be orally administered. The dose levels may change subject to available nonclinical, clinical, safety, and PK data.
Study NCT05667779 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A placebo comparator will be administered at all dose levels.
Study NCT05480020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 toothpaste
Description: Probiotics Streptococcus salivarius M18 toothpaste 1 million cfu/g~In this study, a toothpaste formulation containing S. salivarius M18 will be evaluated for its potential for delivering the probiotic to the oral cavity.
Study NCT05480020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 toothpaste
Description: Probiotics Streptococcus salivarius M18 toothpaste 10 million cfu/g~In this study, a toothpaste formulation containing S. salivarius M18 will be evaluated for its potential for delivering the probiotic to the oral cavity.
Study NCT05480020 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 toothpaste
Description: Probiotics Streptococcus salivarius M18 toothpaste 100 million cfu/g~In this study, a toothpaste formulation containing S. salivarius M18 will be evaluated for its potential for delivering the probiotic to the oral cavity.
Study NCT04848883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advanced AMS program
Description: 1. - Telephone acces to infectious disease experts to discuss patients' therpies during working days.~2. - Biweeckly meetings with infectious diseases experts and antimicrobial stewardship group.
Study NCT04848883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard AMS program
Description: 1. - Educational materials.~2. - Updated local antibiotic guidelines.~3. - Promotion of delayed antibiotic prescription.~4. - Promotion of Streptococcus pyogenes antigen test (Streptotest) if bacterial tonsillitis is suspected.~5. - Daily report to GP of multiresistant bacteria isolates in urinary samples.~6. - Quarterly reports to prescribers of AMS outcomes at the centre-level.
Study NCT04848883 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard AMS program
Description: 1. - Educational materials.~2. - Updated local antibiotic guidelines.~3. - Promotion of delayed antibiotic prescription.~4. - Promotion of Streptococcus pyogenes antigen test (Streptotest) if bacterial tonsillitis is suspected.~5. - Daily report to GP of multiresistant bacteria isolates in urinary samples.~6. - Quarterly reports to prescribers of AMS outcomes at the centre-level.
Study NCT06391216 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus helveticus R0052 and Bifidobacterium longum R0175
Description: 8-week supplementation (56 days); 3 × 10\^9 CFU/day
Study NCT06391216 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 8-week supplementation (56 days)
Study NCT05582096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3457263
Description: Administered SC.
Study NCT05582096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Description: Administered SC.
Study NCT05582096 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tirzepatide
Description: Administered SC.
Study NCT05582096 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study NCT05559853 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CEST-MRF
Description: CEST-MRF enables accurate quantification of both proton exchange rates and volume fractions in a fraction of the time required by conventional pulse sequences will be developed and optimized.
Study NCT04511416 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin XR, 500-2000mg nocte
Description: Metformin XR, 500-2000mg nocte
Study NCT04511416 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metformin XR, 500-2000mg nocte
Description: Metformin XR, 500-2000mg nocte
Study NCT04959760 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2.
Description: The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2 in fingestick capillary blood and plasma samples.
Study NCT06493136 — intervention group
Intervention type: DRUG
Intervention: lidocaine gel
Description: questionnaire
Study NCT04875832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing - EMDR
Description: EMDR is a comprehensive psychotherapy approach, originally developed to treat the victims of trauma. EMDR is guided by an information processing model known as the Adaptive Information Processing (AIP) model. One of the key assumptions of the AIP model is that dysfunctionally stored (disturbing) memories are the cause of several mental pathologies. EMDR is therefore used to address a range of complaints that follow distressing life experiences and it~is characterized by an eight-phase psychotherapy approach. The intervention is based on the use of bilateral stimulation (e.g., taps, tones, or eye movements), which aims to stimulate the information processing system of the brain in combination with other methods of established psychotherapies. EMDR is widely recognized as an empirically supported treatment for post-traumatic stress disorder (PTSD) and it is one of the best psychological treatment focused on the ri-processing of recent traumatic experiences
Study NCT05493384 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation Group
Description: The program will include stretching, strengthening, breathing, posture, proprioceptive, relaxation exercises and segmental extremity movements. Each exercise will be performed 10 times in a session for the first 4 weeks and 15 times for the last 4 weeks. Exercises will be performed progressively on the patients.
Study NCT06358911 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Poly amido amine dendrimer (PAMAM)
Description: Desensitizing agents was applied once after the bleaching procedure,as follows:~1-Bleaching/PAMAM group, patients received bleaching followed by the application of PAMAM for 30 minutes according to previous studies.